Last updated: April 6, 2026

Adequan for Dogs: The Injectable Joint Supplement That Protects Cartilage

When a dog starts slowing down on walks, hesitating before jumping onto the couch, or getting stiff after a nap, joint pain is often the reason. Osteoarthritis affects roughly one in four dogs over the course of their lifetime, and for many owners, the search for effective treatment leads to a product that sits in a category of its own. Adequan for dogs is not a typical supplement and it is not a simple painkiller. It is the only FDA-approved injectable drug classified as a disease-modifying osteoarthritis agent (DMOA) for canines, and it works in ways that most joint supplements cannot match.

If your veterinarian has mentioned Adequan or you have been researching options for a dog with joint problems, this guide covers everything you need to understand — from how the drug works at the cartilage level to what a realistic treatment schedule looks like, what it costs, and what side effects to watch for.

What Is Adequan and How Does It Work?

Adequan Canine is the brand name for polysulfated glycosaminoglycan, or PSGAG. It is manufactured by American Regent Animal Health and has been on the market since 1997. Unlike oral joint supplements that must survive the digestive tract before any active ingredient reaches the joints, Adequan is delivered by intramuscular injection, which allows the drug to enter the bloodstream directly and concentrate in joint cartilage within two hours of administration.

The mechanism of action is what separates Adequan from other joint treatments. It works through several simultaneous pathways:

• Enzyme inhibition. Adequan blocks the activity of destructive enzymes — particularly those in the metalloproteinase family — that break down cartilage in arthritic joints. By slowing this breakdown, it helps preserve the cartilage a dog still has.
• Cartilage repair stimulation. The drug promotes the synthesis of proteoglycans and collagen, two structural components essential to healthy cartilage. This means it does not just slow damage — it actively supports the repair process.
• Synovial fluid improvement. Adequan helps restore the thickness and lubricating quality of synovial fluid, the substance that cushions and nourishes the joint. Better synovial fluid means less friction during movement.
• Anti-inflammatory effects. While not classified as an anti-inflammatory drug, Adequan has demonstrated the ability to reduce inflammation within the joint capsule, which contributes to pain relief.

This combination of protective and restorative effects is why Adequan is described as disease-modifying rather than merely symptom-managing. Most pain medications mask discomfort without addressing the underlying cartilage loss. Adequan targets the disease process itself.

Which Dogs Benefit Most from Adequan?

Adequan is FDA-approved specifically for the treatment of osteoarthritis in dogs, and it tends to produce the best results when started early in the disease process — before cartilage damage becomes severe. Dogs with mild to moderate osteoarthritis often show the most dramatic improvement, though dogs with advanced disease can still benefit from reduced pain and slowed progression.

Certain dogs are especially likely candidates for Adequan treatment:

• Large and giant breeds prone to hip dysplasia, elbow dysplasia, or early-onset joint disease. Breeds like German Shepherds, Labrador Retrievers, Golden Retrievers, Great Danes, and Rottweilers frequently develop osteoarthritis well before old age. You can explore breed-specific health tendencies in our dog breeds directory.
• Senior dogs showing signs of age-related joint stiffness and reduced mobility.
• Post-surgical patients recovering from procedures like cruciate ligament repair or joint surgery, where protecting remaining cartilage is a priority.
• Active and working dogs whose joints take on significant daily stress and who need long-term joint protection.
• Dogs who cannot tolerate NSAIDs. Some dogs experience gastrointestinal, kidney, or liver side effects from non-steroidal anti-inflammatory drugs. Adequan offers a different mechanism that avoids those particular risks.

It is worth noting that Adequan is a prescription medication. Your veterinarian will need to confirm an osteoarthritis diagnosis — typically through a combination of physical examination, history, and radiographs — before prescribing treatment.

Dosing Schedule and Administration

The standard Adequan protocol for dogs is well-established and straightforward. The FDA-approved dosing schedule is:

• Dose: 2 mg per pound of body weight (approximately 4.4 mg/kg)
• Frequency: One intramuscular injection twice per week
• Duration: Up to eight injections over four weeks (the “loading phase”)

After the initial loading phase, many veterinarians recommend ongoing maintenance injections. While the FDA label covers only the initial eight-injection course, it is common veterinary practice to continue treatment with injections every two to four weeks to maintain the benefits. Your vet will tailor the maintenance schedule to your dog’s specific response and needs.

The injections are given intramuscularly, usually in the large muscle groups of the hind legs or the lumbar area. Many veterinarians will teach owners to give the injections at home after the first few sessions, which significantly reduces cost and inconvenience. The needles used are relatively small, and most dogs tolerate the process well — many barely react to the injection at all.

What to Expect: Timeline of Results

Adequan is not an instant pain reliever. Because it works by modifying the disease process rather than simply blocking pain signals, the timeline for visible improvement is measured in weeks rather than hours. Here is a general idea of what to expect:

Weeks one through two: The drug is building up in joint tissues. Some owners report subtle early improvements — a bit more willingness to move, slightly less stiffness after rest — but dramatic changes are unlikely at this stage.

Weeks three through four: This is when most owners notice meaningful differences. Dogs often become more willing to take longer walks, play more readily, and move with less visible discomfort. Stiffness after rest may be noticeably reduced.

Weeks four through eight: Continued improvement is typical, and the benefits often become more pronounced as the full course of treatment completes and maintenance injections continue. Some owners describe the change as their dog “acting years younger.”

Not every dog responds at the same rate, and a small percentage of dogs show minimal improvement. If there is no noticeable benefit after a full course of treatment, your veterinarian may reassess the diagnosis or adjust the treatment plan. In most cases, though, the response rate is encouraging — the majority of dogs treated with Adequan show measurable improvement in mobility and comfort.

Side Effects and Safety Considerations

One of Adequan’s strongest selling points is its safety profile. Side effects are uncommon and typically mild when they do occur. The most frequently reported issues include:

• Pain or swelling at the injection site. This is the most common side effect and is usually minor and short-lived.
• Diarrhea. Occasionally reported, usually resolving without intervention.
• Temporary depression or lethargy. Some dogs may seem slightly subdued for a day after injection.

Because Adequan has mild anti-coagulant properties (it is chemically related to heparin), it should be used with caution in dogs with bleeding disorders or those already taking blood-thinning medications. It is also generally avoided in dogs with known hypersensitivity to PSGAG and in dogs with liver or kidney disease, unless the veterinarian determines the benefits outweigh the risks.

Adequan should not be used in dogs with active joint infections, as the treatment is intended for degenerative disease rather than infectious conditions. Pregnant dogs should also not receive Adequan, as its safety during pregnancy has not been established.

Adequan vs. Oral Joint Supplements

Many dog owners wonder how Adequan compares to over-the-counter joint supplements like glucosamine and chondroitin. The differences are substantial:

Bioavailability. Oral glucosamine supplements must pass through the digestive tract, where absorption is highly variable. Studies suggest that only a small fraction of the oral dose reaches joint tissues. Adequan bypasses digestion entirely, delivering the active compound directly into the bloodstream and concentrating in cartilage within hours.

FDA approval. Adequan is an FDA-approved drug with clinical data supporting its efficacy. Most oral joint supplements are classified as nutraceuticals and are not subject to the same regulatory standards, which means quality and potency can vary significantly between brands.

Mechanism of action. While glucosamine provides a building block for cartilage, it does not actively inhibit the enzymes responsible for cartilage destruction. Adequan does both — it provides structural components and blocks the destructive process simultaneously.

Clinical evidence. The evidence base for Adequan is stronger and more consistent than for most oral supplements. That said, the two approaches are not mutually exclusive. Many veterinarians recommend Adequan alongside oral supplements, fish oil, and other supportive treatments as part of a comprehensive joint health strategy.

Cost of Adequan for Dogs

Cost is a practical reality that factors into every treatment decision. Adequan is more expensive than oral supplements, though many owners find the investment worthwhile given the results.

A 5 mL vial of Adequan Canine (100 mg/mL) typically costs between $60 and $90, depending on the veterinary clinic or pharmacy. The number of vials needed depends on the dog’s weight — larger dogs require larger doses and will go through more product. For a 50-pound dog, the initial eight-injection loading phase might cost roughly $200 to $400 in medication alone, plus any veterinary visit fees for the first few injections.

Once owners learn to administer injections at home, ongoing maintenance costs decrease significantly. Monthly maintenance for a medium-sized dog typically runs $30 to $70 per month in medication costs. Some veterinary pharmacies and online pet pharmacies offer discounts on multi-vial purchases, and it is worth asking your veterinarian about the most cost-effective purchasing options.

Combining Adequan with Other Treatments

Adequan works well as part of a multimodal approach to joint disease. In fact, most veterinary pain specialists recommend combining several strategies for the best outcome. Common complementary treatments include:

• Weight management. Maintaining a healthy body weight is one of the single most impactful things you can do for a dog with joint disease. Every extra pound adds stress to compromised joints.
• Controlled exercise. Low-impact activities like leash walking and swimming help maintain muscle mass and joint flexibility without excessive impact.
• NSAIDs. When appropriate, anti-inflammatory medications can be used alongside Adequan for pain control. Your vet will monitor for any interactions.
• Physical rehabilitation. Hydrotherapy, therapeutic exercises, and laser therapy are increasingly available and can complement Adequan treatment effectively.
• Omega-3 fatty acids. Fish oil supplements provide natural anti-inflammatory support and are generally well-tolerated alongside Adequan.

The goal of a multimodal approach is to address joint disease from every available angle — reducing inflammation, protecting cartilage, managing pain, strengthening supporting muscles, and minimizing excess joint load. Adequan is a powerful component of that strategy, but it delivers the best results when it is not expected to do the job alone.

Frequently Asked Questions

How long does Adequan take to work in dogs?

Most dogs begin to show noticeable improvement within three to four weeks of starting treatment, which corresponds to the second half of the loading phase. Some dogs show subtle improvements earlier, while others may take the full eight-injection course before the benefits become clearly visible. Because Adequan works by modifying the disease process rather than simply blocking pain, patience during the early weeks is important.

Can I give my dog Adequan injections at home?

Yes. Many veterinarians encourage owners to learn home administration after the first few injections are given at the clinic. Intramuscular injections are relatively simple to learn, and most dogs tolerate them well. Your vet will show you proper technique, including how to locate the injection site, handle the syringe, and store the medication. Home administration significantly reduces the cost and inconvenience of ongoing treatment.

Is Adequan the same as glucosamine?

No. While both are related to glycosaminoglycans — molecules involved in cartilage structure — they are quite different. Adequan is a polysulfated glycosaminoglycan delivered by injection with FDA-approved disease-modifying claims. Glucosamine is an amino sugar typically given orally as a dietary supplement. Adequan has stronger clinical evidence, higher bioavailability, and a dual mechanism that both protects existing cartilage and inhibits destructive enzymes. The two can be used together, but they are not interchangeable.

Are there any breeds that should not take Adequan?

Adequan is not breed-restricted. It is approved for use in dogs of all breeds and sizes. However, individual dogs with bleeding disorders, liver disease, kidney disease, or known hypersensitivity to PSGAG should not receive Adequan without careful veterinary evaluation. Breed is less relevant than individual health status when determining suitability for treatment.

Does Adequan cure arthritis in dogs?

No. Osteoarthritis is a progressive, degenerative condition with no cure in either dogs or humans. What Adequan does is slow the progression of the disease, protect remaining cartilage from further breakdown, support the body’s natural repair processes, and improve comfort and mobility. Many dogs on Adequan experience a significant improvement in quality of life, but the underlying condition is managed rather than eliminated.

Can Adequan be used in young dogs?

Yes. Adequan can be particularly valuable in younger dogs who have been diagnosed with early joint disease — for example, a young Labrador Retriever with hip dysplasia or a dog recovering from a joint injury. Starting treatment early, when more cartilage is still intact, gives Adequan the best possible foundation to work with. Your veterinarian will determine whether the diagnosis warrants treatment at a younger age.

Giving Your Dog the Best Chance at Comfortable Movement

Joint disease is one of the most common challenges that dogs and their owners face, particularly as dogs age or in breeds predisposed to orthopedic problems. Adequan for dogs represents one of the most evidence-backed tools available for addressing that challenge at its source — not just masking pain, but actively working to preserve and restore the cartilage that makes pain-free movement possible.

If you suspect your dog is developing joint problems, a conversation with your veterinarian is the essential first step. Early intervention consistently produces the best outcomes, and treatments like Adequan are most effective when there is still healthy cartilage to protect. Combined with weight management, appropriate exercise, and a thoughtful overall care plan, Adequan can help many dogs maintain an active, comfortable life for years longer than the disease might otherwise allow.

If you are looking to bring a dog into your life and want to understand the joint health tendencies of different breeds before you commit, our dog breeds directory is a helpful resource. And if you are ready to give a dog a second chance at a happy, well-cared-for life, take a look at the dogs currently available through our adoption page.